Related Experiment Videos
The influence of infarction site and size on the ventricular response to coronary thrombolysis
Insights
Myocardial infarction (MI) size, not location, significantly impacts ventricular function after reperfusion therapy. Large MIs show improved ejection fraction, while small inferior MIs may worsen, suggesting size is key for treatment decisions.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Myocardial infarction (MI) location and size are critical factors in cardiac recovery.
- Understanding the impact of reperfusion therapy on ventricular function is essential for patient outcomes.
Purpose of the Study:
- To investigate whether myocardial infarction (MI) size or location is the primary determinant of ventricular response to reperfusion.
- To evaluate the efficacy of intracoronary streptokinase in patients with varying MI characteristics.
Main Methods:
- Studied 69 patients receiving intracoronary streptokinase within five hours of chest pain onset.
- Assessed myocardial infarction (MI) size using ejection fraction (EF) at reperfusion (<50% for large MI).
- Compared ventricular functional response (EF changes) between anterior and inferior MIs, categorized by size.
Main Results:
- Large anterior and inferior MIs showed significant increases in EF post-reperfusion.
- Small anterior MIs had minimal EF improvement, while small inferior MIs experienced a significant EF decrease.
- No significant differences in diseased vessels, stenosis, or collaterals were observed between groups.
Conclusions:
- Myocardial infarction (MI) size, rather than its anatomical site, largely dictates the ventricular functional recovery after early reperfusion.
- Inferior MIs should not be excluded from thrombolytic therapy solely based on location; size is a more critical prognostic factor.
Abstract:
To test the hypothesis that myocardial infarction (MI) size rather than location determines the ventricular response to reperfusion, we studied 69 patients receiving intracoronary streptokinase within five hours of chest pain onset who displayed sustained reperfusion at 8.4 +/- 3.4 (SD) days. Twenty reperfusion failures served as controls. There were 31 patients with anterior MIs, 18 of which were estimated to be large based on an ejection fraction (EF) at reperfusion of less than 50%; 14 of 38 patients with inferior MIs also had large MIs. The EF increased at follow-up by 6.4% +/- 2.6% in patients with large anterior MIs and by 8.2% +/- 2.5% in those with large inferior MIs; in contrast, it increased by only 1.8% +/- 2.6% in patients with small anterior MIs and significantly decreased by 5.8% +/- 1.9% in patients with small inferior MIs. Six controls with large MIs (four anterior) displayed no change in EF; in 14 with small MIs (ten inferior), it fell slightly. There were no significant group differences in the number of diseased vessels, residual stenosis, or collaterals. It is concluded that MI size, not site, largely determines the ventricular functional response to early reperfusion; thus, patients with inferior MIs cannot be disqualified on this basis alone for thrombolytic therapy.